The term “chiral pseudohomogeneous
catalyst (PHC)”
denotes a novel concept that characterizes subnanometric particles
exhibiting atomic-level chirality. The PHC based on chiral amphiphilic
carbon quantum dots possesses distinctive features that combine the
strengths of both homogeneous and heterogeneous catalysts, thereby
heralding a significant breakthrough in the fields of asymmetric synthesis
and medicinal chemistry. To the best of our knowledge, this is the
first and the only reported research of a chiral PHC that demonstrates
exceptional performance in controlling the enantioselectivity of the
Kharasch–Sosnovsky reaction, yielding the corresponding products
in high conversion (95%) with a moderate enantiomeric excess (75%).
Notably, the chiral information on l-tryptophan can be effectively
transferred from the outer shell of the nanosized catalyst, thereby
inducing enantioselectivity in C–H activation and subsequent
C–O forming events. Additionally, we have investigated the
impact of various factors on the allylic oxidation reaction, including
the amount, diversity, and hydrophilic/hydrophobic nature of the catalyst,
as well as the influence of the solvent, Cu salts, temperature, and
the type of alkene and perester, in order to comprehensively explore
the reaction conditions. Furthermore, the catalyst can be readily
recycled from the reaction medium, making this PHC a promising innovation
that can significantly impact practical applications. In summary,
this breakthrough can be aptly described as a “Golden Gate”
due to its unparalleled potential to open up novel avenues for research
and innovation.